Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adia MedADIA 14 PS Ratio is 16.56 as of Aug. 01, 2026, which is 7% below its 10-year median of 17.78. GuruFocus rates ADIA with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Adia Med ranks worse than 94.68% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Adia Med's share price is $0.149.
Adia Med's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01. Hence, Adia Med's PS Ratio for today is 16.56.
The historical rank and industry rank for Adia Med's PS Ratio or its related term are showing as below:
ADIA'
s PS Ratio Range Over the Past 10 Years
Min: 4.29 Med: 17.78 Max: 90
Current: 16.56
During the past 2 years, Adia Med's highest PS Ratio was 90.00. The lowest was 4.29. And the median was 17.78.
ADIA's PS Ratio is ranked worse than 94.68% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs ADIA: 16.56
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Adia Med PS Ratio Related Terms
Adia Med PS Ratio Historical Data
* Premium members only.
The historical data trend for Adia Med's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Adia Med's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adia Med PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Adia Med's PS Ratio distribution charts can be found below:
* The bar in red indicates where Adia Med's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Adia Med's Share Price of today is $0.149. Adia Med's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Adia Med (ADIA) has a PS Ratio of 16.56 as of Aug. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Adia Med and its competitors. This is near median its historical median of 17.78. Over the past decade, Adia Med's PS Ratio has ranged from 4.29 to 90.00. According to the industry distribution chart, Adia Med ranks #623 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 94.7%.
Is Adia Med's PS Ratio too high?
Adia Med's current PS Ratio of 16.56 is near median its 10-year median of 17.78. Over the past 10 years, this metric has ranged from a low of 4.29 to a high of 90.00. The Healthcare Providers & Services industry median PS Ratio is 1.47. Adia Med's value of 16.56 is 1026.5% above this industry median. Based on the distribution chart, Adia Med ranks #623 out of 658 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Adia Med has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Adia Med's PS Ratio compare to GBCS and CCM?
According to the Healthcare Providers & Services industry distribution chart, Adia Med ranks #623 out of 658 companies for PS Ratio. This places Adia Med in the lower half of its industry. The industry median PS Ratio is 1.47. Adia Med's value of 16.56 is 1026.5% above this benchmark. Historically, Adia Med's own PS Ratio has ranged from 4.29 to 90.00 over the past decade. While the company's 10-year median is 17.78 vs. the industry median of 1.47, Adia Med has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adia Med's current PS Ratio of 16.56 is 1026.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Adia Med and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adia Med's current PS Ratio is 16.56, which is near median its own 10-year median of 17.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adia Med stock overvalued right now?
Adia Med (ADIA) has a current PS Ratio of 16.56. The current PS Ratio is 16.56, which is near median its 10-year median of 17.78 and 1026.5% above the Healthcare Providers & Services industry median of 1.47. Adia Med's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Adia Med (ADIA), the current PS Ratio is 16.56 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adia Nutrition Inc focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Its products and the deployment of the therapies utilizing its products address various orthopedic issues, pain management, and wound repair. In addition, its products are able to be utilized in various other therapies to address anti-aging issues and other tissue repair desires. It operates in three segments The Biolete segment comprises the sale of supplements; Adia Med performs stem cell treatments to patients; and Adia Labs procures and sells stem cell products to outside clinics or to Adia Med. It derives revenue from Sales of supplements, Medical procedures, Sales of biologics and ancillary products.
14GF Score
Get the complete analysis for ADIA
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADIA has been successfully added to your 
